XBiotech discontinues phase III study for colorectal cancer antibody therapy - 4 insights | 28 latest hospital, health system executive moves | 5 most-read GI/endoscopy stories | UHS hospital in Oklahoma faces Medicare termination on heels of Buzzfeed News investigation

June 13, 2017

Today's Top Stories

1. Liver cancer rates expected to increase through 2030 - 5 report insights

Full story

2. XBiotech discontinues phase III study for colorectal cancer antibody therapy - 4 insights Full story

3. 28 latest hospital, health system executive moves Full story

4. Webinar: Why is health IT turning to hyperconverged infrastructure (HCI) to help application deployment? To learn more and register, click here.

5. UHS hospital in Oklahoma faces Medicare termination on heels of Buzzfeed News investigation Full story

6. 5 most-read GI/endoscopy stories Full story

7. Webinar: Better Healthcare - With Less IT Complexity: Lessons Learned by the Largest U.S. Specialty Health Plan. Register today!

8. Need to sharpen your colonoscopy skills? There's an app for that Full story

9. Kentucky judge grants CON ASC approval to The Christ Hospital: 5 key points Full story

10. Gastroenterologists ignoring H.pylori guidelines, survey says - 3 insights Full story

11. Yelp, Vitals, Healthgrades physician ratings don't match quality scores: 5 key notes
Full story

12. GI leader to know: Dr. Andrew Riegel of Emerald Coast Gastroenterology Full story

Companies to Know

Thank you to our sponsors

Paradigm Spine

Pacira Pharmaceuticals

Cardinal Health

National Medical Billing Services

McKesson Medical Surgical

Medline Industries, Inc.

CollectRX

North American Partners in Anesthesia

Regent Surgical Health

Modernizing Medicine

ECG Management Consultants
Arthrex, Inc.
Zimmer Biomet
Surgical Care Affiliates
AAAHC
Healthcare Appraisers, Inc.
ASCOA
Olympus America
Anesthesia Business Consultants
Doc Halo